What is Bartholin gland carcinoma?
Bartholin gland carcinoma is a rare cancer of the vulva that starts in one of the Bartholin glands. These are two small, pea-sized glands that sit on either side of the vaginal opening. They release fluid that helps keep the vulva moist.
Most problems with these glands are benign. A Bartholin cyst forms when the duct becomes blocked, and an abscess forms when that cyst becomes infected. Both are common, especially in younger women. Cancer of the gland is uncommon, accounting for only a small share of vulval cancers, roughly 3-7% (Kostov et al., 2025).
Because the cancer can look and feel like a cyst or abscess, it is often diagnosed late. About half of cases are found at an advanced stage (Kostov et al., 2025). For this reason, doctors recommend that a new Bartholin swelling in a woman over 40, or one that keeps returning, is examined carefully and sampled.
Bartholin gland carcinoma is not a single disease. The gland contains several kinds of cell, and cancer can arise from any of them. The three main types are squamous cell carcinoma, adenoid cystic carcinoma and adenocarcinoma, and each behaves differently (Di Donato et al., 2017). Treatment usually involves surgery to remove the tumour and check the groin lymph nodes, often followed by radiotherapy.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of cancer | Carcinoma arising in the Bartholin gland of the vulva |
| How common | Rare; about 3-7% of vulval cancers |
| Typical age | Usually 40s-70s; HPV-related cases can occur younger |
| Main types | Squamous cell carcinoma, adenoid cystic carcinoma, adenocarcinoma |
| Usual first sign | A firm lump at the side of the vaginal opening |
| Common misdiagnosis | Bartholin cyst or abscess |
| Lymph node spread | In more than 40% of cases |
| Main treatment | Wide excision, groin node assessment, often radiotherapy |
| Outlook | Variable; worse with lymph node spread or adenocarcinoma |
2. Types of Bartholin gland carcinoma
A review of 275 published cases found that squamous cell carcinoma, adenoid cystic carcinoma and adenocarcinoma each made up roughly a quarter to a third of cases (Di Donato et al., 2017).
| Type | Share in pooled data | Key features |
|---|---|---|
| Squamous cell carcinoma | About 31% | Arises near the duct opening; may be linked to HPV |
| Adenoid cystic carcinoma | About 30% | Slow growing; spreads along nerves; late recurrences, often in the lungs |
| Adenocarcinoma | About 25% | Arises from the gland itself; linked with a poorer outlook |
| Other types | The remainder | Adenosquamous, transitional cell, small cell and other rare types |
Molecular clues
Laboratory tests help confirm the type and rule out spread from another organ (Kostov et al., 2025).
| Test | Use |
|---|---|
| p16 or HPV testing | Identifies HPV-associated squamous cell carcinoma |
| MYB or MYBL1 gene fusions | Support adenoid cystic carcinoma |
| CK20, CDX2, SATB2 stains | Identify intestinal-type adenocarcinoma and help exclude bowel cancer spread |
Bartholin cyst, abscess or cancer?
| Feature | Cyst | Abscess | Carcinoma |
|---|---|---|---|
| Onset | Gradual | Quick, over days | Gradual, over weeks or months |
| Pain | Usually painless | Very painful, hot, red | Often painless at first |
| Feel | Soft, smooth | Tense and tender | Firm, hard or fixed |
| Age | Often under 40 | Any age | Usually over 40 |
| After drainage | May recur | Usually settles | Persists or regrows |
3. Causes and risk factors
| Risk factor | Notes |
|---|---|
| Age over 40 | Most cases occur in midlife or later |
| Human papillomavirus (HPV) | Linked with some squamous cell carcinomas, usually in younger women |
| Smoking | Increases the risk of HPV-related cancers |
| Weakened immune system | Raises the risk of HPV-related disease |
| Previous Bartholin cysts | No proven link, but recurring swellings should be checked |
The cause of adenoid cystic carcinoma and adenocarcinoma of the gland is not known. Women with HPV-associated tumours tend to be younger and to do better than those with other types (Kostov et al., 2025).
4. How does it look
On examination
| Feature | Description |
|---|---|
| Position | Low on one side of the vaginal opening, deep in the labia |
| Lump | Firm, solid, sometimes fixed to deeper tissue |
| Surface | Normal skin, or an ulcer in advanced cases |
| Size | From 1 cm to several centimetres |
| Groin | Enlarged lymph nodes in some women |
On scans
| Test | What it shows |
|---|---|
| MRI of the pelvis | Size, depth and spread to the vagina, rectum or pelvic floor |
| CT or PET-CT | Lymph node and distant spread |
| Ultrasound of the groins | Groin node size; may guide a needle biopsy |
Under the microscope
The pathologist confirms that the cancer comes from the Bartholin gland itself, ideally by finding a transition from normal gland tissue to tumour, and excludes spread from elsewhere.
5. Symptoms
Common symptoms
- A lump at the side of the vaginal opening
- Discomfort or pain, especially when sitting, walking or during sex
- A “cyst” that keeps coming back or does not go away after drainage
Less common symptoms
| Symptom | What it may mean |
|---|---|
| Bleeding or discharge | Ulceration of the tumour |
| Itching or burning | Irritation of the vulval skin |
| Lump in the groin | Spread to lymph nodes |
| Pain spreading to the buttock or leg | Nerve involvement, especially with adenoid cystic carcinoma |
| Bowel or urinary symptoms | Advanced local spread |
When to seek medical advice
See a doctor or gynaecologist if you notice a new lump near the vaginal opening, particularly if you are over 40, if it is firm and painless, or if a previously treated cyst returns. Most such lumps are benign, but they should be examined.
6. Diagnosis
| Test | Purpose |
|---|---|
| Pelvic and groin examination | Assesses the lump and lymph nodes |
| Biopsy | Confirms cancer and type; often needed for any solid Bartholin mass in women over 40 |
| Excision of the gland | Sometimes performed for diagnosis |
| MRI of the pelvis | Local extent |
| CT or PET-CT | Spread to nodes and distant organs |
| Groin ultrasound with needle sampling | Assesses suspicious nodes |
| Colposcopy and cervical screening | Checks for other HPV-related changes |
Staging
Bartholin gland carcinoma is staged using the FIGO system for vulval cancer.
| Stage | General meaning |
|---|---|
| Stage I | Confined to the vulva or perineum |
| Stage II | Extends to the lower urethra, lower vagina or anus |
| Stage III | Spread to groin lymph nodes or upper parts of nearby organs |
| Stage IV | Fixed to bone, involves bladder or rectal lining, or distant spread |
7. Treatment
Treatment should take place in a specialist gynaecological oncology centre (Ouldamer et al., 2013). Because the disease is so rare, care follows the principles used for vulval cancer, adapted to the tumour type.
Surgery
| Procedure | Purpose |
|---|---|
| Radical local excision | Removes the tumour with a margin of healthy tissue |
| Radical hemivulvectomy | Removes one side of the vulva for larger tumours |
| Sentinel lymph node biopsy | Samples the first draining groin node, in selected small tumours |
| Inguinofemoral lymphadenectomy | Removes groin nodes; often both sides are assessed |
| Reconstruction | Skin flaps to close larger wounds |
Recent guidance stresses complete removal with clear margins and assessment of the groin nodes on both sides (Kostov et al., 2025).
Radiotherapy
| Situation | Role |
|---|---|
| Close or positive margins | Lowers local recurrence |
| Positive lymph nodes | Treats the groins and pelvis |
| Adenoid cystic carcinoma | Often advised because of spread along nerves |
| Tumours that cannot be removed | Chemoradiotherapy as main treatment |
In an early series of 36 patients, local recurrence was much less frequent in women who received radiotherapy than in those who did not (Copeland et al., 1986).
Chemotherapy and newer drugs
| Treatment | Use |
|---|---|
| Cisplatin with radiotherapy (chemoradiotherapy) | Advanced squamous cell carcinoma |
| Platinum-based chemotherapy | Spread to distant organs |
| Immune checkpoint inhibitors | Emerging evidence in squamous tumours |
| Targeted drugs | Being explored in adenocarcinoma, guided by molecular tests |
Side effects
| Treatment | Possible side effects |
|---|---|
| Vulval surgery | Wound breakdown, infection, change in appearance, pain during sex |
| Groin node surgery | Leg swelling (lymphoedema), fluid collections, numbness |
| Radiotherapy | Skin soreness, vaginal dryness and narrowing, bowel and bladder irritation |
| Chemotherapy | Tiredness, nausea, low blood counts |
What treatment involves day to day
| Stage | What to expect |
|---|---|
| Surgery | Usually 2-7 days in hospital, depending on the extent |
| Wound healing | Several weeks; careful hygiene and dressings |
| Radiotherapy | Weekday sessions for about 5-6 weeks |
| Recovery of sexual function | Gradual; vaginal dilators and lubricants help |
8. Outlook (prognosis)
| Factor | Effect on outlook |
|---|---|
| Lymph node involvement | The strongest predictor of worse survival |
| Adenocarcinoma type | Poorer outlook than other types |
| HPV-associated squamous carcinoma | Generally better outlook |
| Adenoid cystic carcinoma | Good early survival, but late recurrences and lung spread |
| Clear margins and radiotherapy where needed | Lower risk of local recurrence |
| Advanced stage at diagnosis | Poorer outlook |
In pooled data, adenocarcinoma and positive lymph nodes were both linked with poorer survival (Di Donato et al., 2017). In the series by Copeland and colleagues, about five in six women were alive at five years after combined treatment (Copeland et al., 1986).
Lessons from a 30-year hospital series
One of the largest single-centre reports described 36 women treated over three decades (Copeland et al., 1986).
| Finding | Result |
|---|---|
| Most common type | Squamous cell carcinoma (27 of 36) |
| Stage spread | Most women had stage I or II disease |
| Nodes involved when removed | 14 of 30 women (47%) |
| Recurrences | 9 women, mostly in the vulva |
| Local recurrence with radiotherapy | 1 of 14 (7%) |
| Local recurrence without radiotherapy | 6 of 22 (27%) |
| Five-year survival | 84% |
The authors concluded that wide excision, removal of the groin nodes on the affected side and added radiotherapy gave very good results. Modern practice now favours checking both groins (Kostov et al., 2025).
Why the evidence is limited
There have been no randomised trials in this disease, so treatment advice comes from case series, pooled reviews and vulval cancer guidelines (Ouldamer et al., 2013). Experts call for referral to specialist centres and international collaboration so that larger studies become possible (Di Donato et al., 2017).
9. Follow-up
| Follow-up | Purpose |
|---|---|
| Examination every 3-6 months for 2-3 years | Checks the vulva and groins |
| Then every 6-12 months up to 5 years | Continued monitoring |
| Long-term follow-up for adenoid cystic carcinoma | Recurrences can occur many years later |
| Chest imaging | Particularly for adenoid cystic carcinoma |
| Cervical screening | Continue as advised |
10. Living with Bartholin gland carcinoma
- Keep the wound clean and dry while healing, and report redness or discharge
- Wear compression stockings and do leg exercises if you develop lymphoedema
- Use vaginal dilators after radiotherapy if advised, to prevent narrowing
- Talk openly about sex and intimacy; specialist nurses and psychosexual counsellors can help
- Stop smoking, especially with HPV-related cancer
- Report new lumps, bleeding or leg swelling promptly
- Seek support from gynaecological cancer charities
11. Frequently asked questions
| Question | Answer |
|---|---|
| Is a Bartholin cyst cancer? | Almost never; cysts and abscesses are common and benign |
| Why was my cancer first treated as a cyst? | The two can look and feel alike, which is why persistent lumps need a biopsy |
| Is it caused by HPV? | Some squamous cell carcinomas are; other types are not |
| Will I need groin surgery? | Usually the groin nodes are assessed, by sentinel node biopsy or dissection |
| Will sex be possible afterwards? | For many women yes, with time and support |
| Can it come back? | Yes, so regular follow-up is important |
| Is it inherited? | No |
| Why do I need a specialist centre? | The disease is rare, and experienced teams achieve better surgical results |
| Will I need a stoma? | Rarely; only if the bowel is involved in advanced disease |
12. Questions to ask your care team
- Which type of Bartholin gland carcinoma do I have?
- What stage is it, and are my lymph nodes involved?
- What operation do you recommend, and will both groins be checked?
- Will I need radiotherapy or chemotherapy?
- How will treatment affect my sexual function and continence?
- What follow-up will I need, and for how long?
Resources
- Copeland, L.J. et al. (1986) ‘Bartholin gland carcinoma’, Obstetrics and Gynecology, 67(6), pp. 794-801.
- Di Donato, V. et al. (2017) ‘Bartholin gland cancer’, Critical Reviews in Oncology/Hematology, 117, pp. 1-11.
- Kostov, S. et al. (2025) ‘Bartholin gland carcinoma: a state-of-the-art review of epidemiology, histopathology, molecular testing, and clinical management’, Cancers, 17(23), 3819.
- Ouldamer, L. et al. (2013) ‘Bartholin’s gland carcinoma: epidemiology and therapeutic management’, Surgical Oncology, 22(2), pp. 117-122.
- National Cancer Institute (2026) Vulvar Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/vulvar/hp/vulvar-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.